Cardio-Hepatology

Connections Between Hepatic and Cardiovascular Disease

Häftad, Engelska, 2022

1 760 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

Beskrivning

Cardio-Hepatology: Connections Between Hepatic and Cardiovascular Disease provides a direct relationship between the cardiac and hepatic pathologies providing the link between the heart and liver and showing how liver diseases predispose to impairment in heart functioning and vice versa. Considering the growing number of patients living (and living longer) with heart failure and/or congenital heart disease, it is important to know when and how to test for liver disease in this population, how to interpret abnormal test results, and what management is appropriate. Coverage includes what should be done for patients to limit, avoid, or postpone the impairment in the liver functioning induced by heart diseases and the impairment in the heart functioning induced by liver diseases, on the basis of scientific-exposed evidence and pathophysiology knowledge.

This comprehensive, extended review of the medical literature is perfect for researchers interested in the connection between cardiology and hepatology as well as clinicians making therapeutic decisions for patients suffering from heart or liver chronic diseases.

Reviews and discusses all current knowledge about the interactions between heart and liver pathologies
Provides guidance on current topics surrounding the assessment of the liver in heart failure
Presents important clinical cardiovascular assessments in cirrhotic patients

Produktinformation

Utgivningsdatum:2022-09-22
Mått:216 x 276 x 25 mm
Vikt:1 040 g
Format:Häftad
Språk:Engelska
Antal sidor:376
Förlag:Elsevier Science
ISBN:9780128173947

Utforska kategorier

Hepatologi inom Medicin
Hjärt- och kärlsjukdomar inom Medicin

Mer om författaren

Dr. Taniguchi is a cardiologist at the Department of Cardiovascular Medicine at Osaka University Graduate School of Medicine, Japan, with research interests in crosstalk between heart and other organs in heart failure. He has won several awards for research including the 2014 Japan Circulation Society (Kinki Regional Scientific Meeting) Young Investigator’s Award and the Japan Society of Ultrasound Sonics in Medicine Prize for Encouragement. He served as a representative of U-40 heart failure network in Japan in 2018. He is also a member of Japan International Young Committee at Japan Circulation Society from 2018. Dr. Lee is a professor of Medicine (Hepatology) at the University of Calgary, Canada, with research interests in cardiovascular complications of cirrhosis and viral hepatitis. He has won several awards for teaching and research including the Queen Elizabeth II Golden Jubilee Medal in 2002, the Canadian Association of the Study of Liver (CASL) Distinguished Service Award, 2015, CASL/CLF Gold Medal in 2021, and has lectured in more than 50 countries. He is a past-president of CASL, International Association for Study of Liver (IASL), and the International Ascites Club. He served as editor-in-chief of Liver International from 2008 to 2013. He chairs the steering committee for the Canadian HCV database registry CANUHC (Canadian Network Undertaking against Hepatitis C).

Innehållsförteckning

I. Liver and heart1. The liver2. Nonalcoholic fatty liver disease and cardiovascular disease3. Pathophysiologic changes in chronic heart failure affecting drug pharmacokinetics4. Drugs at the crossroads of heart and liver5. Obstruction of the liver circulationII. Hepatobiliary system in heart failure6. Epidemiology of liver diseases in heart failure7. Cardio-hepatology: liver function tests in heart failure8. Prognostic value of liver assessment (including liver stiffness measurement) in cardiovascular diseases9. Passive liver congestion and hypoxic hepatitis10. Histopathology of the liver in heart failureIII. Cardiovascular system in liver failure12. Sepsis and the liver13. Bleeding and thrombosis in cirrhosis14. Peripheral vasculature in portal hypertension15. Cirrhotic cardiomyopathy16. Cardiovascular dysfunction in liver diseases: pediatric perspectives17. Hepatorenal syndrome and acute kidney injury in cirrhosis18. Cardiopulmonary considerations for the anesthetic management of liver transplantation19. Cardiovascular assessment before liver transplantation20. Predicting cardiovascular complications after liver transplantation